The Kennel Club is hosting its second Puppy Awareness Week to help improve the health and lives of dogs around the UK, and is seeking assistance from the veterinary profession.
Puppy Awareness Week is taking place from 8th - 14th September and aims to help people find a healthy, happy puppy that is right for their lifestyle, whilst raising awareness about the plight of puppies and breeding bitches born into cruel puppy farms.
To help, veterinary surgeons and nurses are being asked to join in the week, putting up posters and literature in client waiting areas, and selling Puppy Awareness Week badges for £2, which will go to the Kennel Club Charitable Trust.
Caroline Kisko, Kennel Club Secretary said: "It is vitally important that we spread the word about buying puppies responsibly. At veterinary surgeries there is a captive audience of animal lovers and we can't think of anyone better to communicate with. Not only are a vet's clients animal lovers and as such, potential new dog owners, but they may also make great champions of the cause, spreading the message about buying a puppy responsibly further afield.
"Sadly, we are seeing tens of thousands of puppies born each year suffer as puppy farms churn out litter after litter of undernourished and badly cared for puppies, and then selling them on to unsuspecting owners through pet shops, newspaper ads, online adverts and various other means. With help from veterinary practices we want to provide information throughout Puppy Awareness Week to help people understand how to buy a healthy, happy puppy, and to raise money for the Kennel Club Charitable Trust, which supports charities and organisations that are making dogs' lives better."
To get involved in Puppy Awareness Week and receive literature and Puppy Awareness badges, contact the Kennel Club press office at press.office@thekennelclub.org.uk.
Puppy Awareness Week will kick off at Pup Aid on September 8th in Primrose Hill, London and will run until 14th September. To find out more, visit www.thekennelclub.org.uk/paw.
The new resources include:
Celia Marr, chair of BEVA’s infectious disease working group, said: “Equine disease prevention and management are fundamental for responsible equine health, welfare and performance.
“These resources cover the need-to-know information and are all in one easy reverence location on the newly designed infection control page on the BEVA website.”
https://www.beva.org.uk/Resources/Equine-infectious-diseases
The RCVS reports that its alternative dispute resolution (ADR) trial is now nearing completion with over two-thirds of its target number of cases either resolved or in process.
The year-long trial, which began in November 2014, aims to gather the evidence needed to develop a permanent scheme which would provide a way of adjudicating on concerns raised about a veterinary surgeon that do not meet the RCVS threshold of serious professional misconduct.
The aim of the trial, which is administered by the independent, not-for-profit Ombudsman Services, is to make determinations on around 100 cases in order to gather information about types of concern, time taken to resolve disputes, recommendations and how likely each party is to accept recommendations. As of this week some 72 cases have been referred to the trial scheme, with final decisions made in relation to 54 of these cases.
RCVS CEO Nick Stace was responsible for pushing forward the trial believing that “what is good for the consumer is good for the profession”. The College also says it brings it into line with a European Union Directive on alternative dispute resolution which, while not legally binding, specifies that regulators and other ‘competent authorities’ should have consumer redress systems in place.
Nick said: “The majority of cases are either being determined in the veterinary surgeon’s favour or finding that they need take no further action in order to resolve the dispute. Where recommendations have been made in favour of the client, the suggested remedies have generally been for a small goodwill payment to be made.
“However, the trial has not been without some frustrations so far. The fact that participation in the trial is entirely voluntary has meant that, in many cases, members of the profession have chosen not to take part.
“With this in mind, it is very important to stress the benefits of the trial to the profession – chiefly that many of the vets who chose to take part have had their actions exonerated by Ombudsman Services in a way that a concern being closed by our Professional Conduct Department does not. For clients, where a vet does have a case to answer, it gives them the chance to seek recompense without having to resort to legal action.
“Regardless of which way the decision goes in any of these cases, participating in the trial can bring these often long-standing and burdensome disputes to a close.”
The trial will continue to run until the end of October and a full report and recommendations will be presented to RCVS Council at its meeting on Thursday 5 November 2015. Full details of the trial and its parameters can be found at www.rcvs.org.uk/adr
Boehringer Ingelheim has launched Bitesize (www.bi-bitesize.co.uk), an educational website about canine epilepsy for veterinary surgeons.
Boehringer’s Brand Manager Craig Roxburgh said: "We have teamed up with eight neurology experts working in referral centres across the UK. These experts have covered the questions most commonly encountered when managing epilepsy cases in first opinion practice, which we hope will assist vets in their epilepsy case management."
Answers to questions are delivered as short video clips of between one and three minutes, optimised for use on smartphones and tablet devices to make them available in the practice or on the move.
Craig added: "Canine epilepsy can be a complex condition to manage. We hope therefore that when cases present, Bitesize will prove a useful and handy ‘go-to’ resource for vets to access information at the time they need it."
There's a chance to win an iPad if you visit the new site before 29th February 2016.
The BVA is calling on Defra and the APHA to take an innovative approach to capturing farm animal post-mortem data, after its Voice of the Veterinary Profession survey found that 90% of production animal vets now conduct their own PMs.
In 2014, there was a 31% increase in production animal vets carrying out their own PMs following post mortem laboratory closures, yet most vets keep this PM data at their practice, with less than 5% inputting it into a national system such as NADIS, AHT or APHA and less than 1% to a benchmarking group.
Sean Wensley BVA President said: "We have heard a lot about big data and its positive uses economically and socially. Disease surveillance could be a shining example of where big data and innovative data capture comes into its own. In a global world, where diseases such as Schmallenberg and bluetongue can emerge in our livestock without having previously been seen on these shores, being able to quickly join up the dots of disparate disease data is vital.
"We understand that Defra and APHA must make difficult choices due to economic pressures and we very much welcome research already utilising post mortem data such as the Agriculture and Horticulture Development Board’s Fallen Stock Project. What we now need is clear communications and guidance on carcase collection and access to PM examination arrangements together with a determination to see this as an opportunity to innovate, exploring how digital technology can help vets in the field record and capture data that feed into national databases and help us to see the bigger picture."
BVA is asking that all vets affected by laboratory closures are clearly informed about alternative arrangements for carcase collection and PMs, with 63% of vets affected by laboratory closures reporting that carcase collection in their local area was not working well.
BVA is calling on government and industry to lead in developing new and cost efficient ways to capture and analyse disease and surveillance data, drawing on innovations in digital technology and big data analysis.
Photograph courtesy BVA
Zoetis has announced that Suvaxyn MH-One, its vaccine against Mycoplasma hyopneumoniae in pigs, has a revised licence allowing it to be administered from seven days of age with a two-week onset of immunity.
The company says this means that piglets can be protected by three weeks of age when they are commonly already infected with M. hyo. Duration of immunity extends well beyond the average UK pig slaughter age of 176 days.
Nigel Lodge, National Veterinary Manager for Zoetis in the UK said: "This is a significant step forward, recognising the full efficacy of the Suvaxyn MH-One vaccine against enzootic pneumonia. Trials have confirmed that use of Suvaxyn MH-One at seven days reduces lung lesions - even in the presence of maternally derived antibodies.
"The vaccine, which adds to our large and growing pig vaccine and product portfolio, also benefits from using adjuvants carbopol and squalane."
According to the company, the performance gains from early protection are shown in a field trial with 240 pigs injected at one week of age which showed significantly higher average daily weight gain, providing nearly 5 kg extra weight over the study period to 166 days.
Abbey Veterinary Group in Chaddesden, Derby has won a dental x-ray system worth £2,500 in a prize draw held by Pedigree.
The competition aimed to encourage veterinary practices to sign up for the inaugural Oral Care Month which saw 1109 clinics educating dog owners on the importance of regular dental care.
Clive McPherson, veterinary partner at Abbey Veterinary Group, said: "We were extremely pleased to hear that we had won the dental x-ray system. We had been planning to upgrade our dental facilities and this was one item that was high on our wish list. The new machine will enable us to carry out our dental work to a higher standard and will be of use in other maxilla facial problems. We expect it to be used daily and we are very grateful to Pedigree for its very generous prize."
Langford Veterinary Services, a fully owned subsidiary of the University of Bristol, has announced the opening of a new standing equine magnetic resonance imaging (MRI) facility at the university's equine centre.
The equine MRI facility completes the diagnostic imaging facilities in the School, which include a 16-slice CT scanner for small animals and standing horses, digital radiography, high-resolution fluoroscopy, diagnostic ultrasound, echocardiography and scintigraphy with a high-resolution 1.5 tesla MRI scanner, available seven days a week.
Evita Busschers, Senior Teaching Fellow and orthopaedic surgeon in the equine centre, said: “We are very grateful to the Trustees of the Alborada Trust and the Langford Trust who have provided generous support for the MRI facility. The new imaging facility will enable us to provide an even better and more complete service for our equine patients and completes the diagnostic imaging facilities available at the centre.
“Equine MRI offers the ability to image soft tissue structures and identify soft tissue injuries that cannot be demonstrated with other diagnostic imaging modalities and therefore has major additional value in providing a diagnosis and prognosis in lameness evaluations.”
Miles Littlewort, a trustee from the Alborada Trust added: “Donating the money is the easy bit but ensuring that it has been used where it should be and that it has made the necessary difference is much more challenging. We are so pleased to have had the opportunity to support the Langford Trust and their work to improve animal health and welfare. We are delighted to have attended the opening, to meet the clinicians who will use the magnificent facility and to learn about the clinical research which gives all veterinary surgeons evidence-based information to enhance diagnosis and treatment for all patients.”
As part of the campaign, vets are invited to share their top tips for maintaining a calm workplace for staff and patients at: https://www.nvsweb.co.uk/products/big-chill.
Veterinary professionals are being asked to share their top tips in two areas. Firstly, on how they prioritise self-care for themselves and teammates, and secondly, on how they best deal with nervous, stressed or anxious patients.
All respondents will be entered into a prize draw for a VetYogi practice subscription.
Gemma Vardy, Senior Category Specialist at NVS Group, said: “Mental health and wellbeing have never been more important within the veterinary industry which is why our dedicated Big Chill campaign supports the wellbeing and mental health of veterinary professionals while also shining a light on animal calming products, such as our select healthcare calming chews, which help support calm and enhance patient experiences.”
https://www.nvsweb.co.uk/products/big-chill
The maps provide vets with a visual representation of targeted diagnostic tests conducted in France, Germany, Ireland, Italy, Spain, and the UK, using data sourced from Idexx.
They show the percentage of positive test results for a range of parasites and parasite-associated infections in dogs and cats, including Giardia, roundworm, and whipworm, and Lyme (Borrelia burgdorferi), Ehrlichia spp., Anaplasma spp., Babesia spp., and Leishmania in dogs.
Data can be filtered by country, region, animal species, parasite type, and time period.
ESCCAP highlights that the data reflects the percentage of positive tests in screened animals, not the overall prevalence of infection.
https://www.esccap.org/parasite-infection-map/
Here’s a gadget I’d love to get my hands on: the Zoombak advanced GPS pet locator, launched in the UK today.
The locator attaches to any dog collar, or indeed your car, husband, wife or teenager, and allows you to get a real time fix of their location by telephone, or on your computer. It costs £99.99 from pet retailers, with an additional £9.99 per month service subscription (£99.99 if paid annually upfront), which allows for an unlimited number of ‘locates’. Hot on its heels comes the Pawtrack, which will also cost £99.99 with a similar monthly subscription which allows for 1200 locates per month.
Pawtrack is being aimed at both cats and dogs, and whilst it is marginally smaller and lighter than the Zoombak, there isn’t a lot in it. Both are still probably too cumbersome for a cat, which is why Zoombak more pragmatically recommends its product for dogs over 7 kg.
Doubtless it won’t be long before they miniaturise the technology so that it’ll be the width of a nostril hair, thereby solving the problem of pet theft and loss completely. Meantime, these look like a practical and fun gadget for the owners of larger breeds that regularly go AWOL.
For more information on stocking Zoombak please contact Zoombak on 08708 033095.
The BSAVA is calling on veterinary surgeons to vote for colleagues that they feel are deserving of one of the Association's prestigious awards.
The awards are:
All members of BSAVA are eligible to vote - either in just one, or multiple categories. Visit www.bsava.com/awards or call 01452 726705 for details.
The deadline for votes is 14 September. The Awards Ceremony will take place at BSAVA Congress 4-7 April 2013.
In addition, the Association is inviting applications for the Frank Beattie Travel Scholarship. Established in 1988 in memory of Frank Beattie, a well respected veterinary surgeon and a long-standing member of the BSAVA, it is awarded annually from a generous gift given by Frank's widow, Annie. The scholarship, worth £2000, is to help a BSAVA member undertake a trip abroad to study a particular aspect of veterinary practice. To apply for this scholarship email h.field@bsava.com or call 01452 726705. The deadline for application is 28 September.
Following a new study published in the journal Emerging Infectious Diseases, the World Small Animal Veterinary Association's One Health Committee has called for a co-ordinated global infectious disease monitoring system to be established for veterinarians who work in small companion animal practice worldwide.
The study, led by Michael Day, Professor of Veterinary Pathology in the School of Veterinary Sciences at the University of Bristol and Chair of the WSAVA's One Health Committee, lists the key zoonotic diseases of cats and dogs.
It recommends that the knowledge gained through surveillance would permit more effective global control of small companion animal zoonoses and reduce the risks associated with the human-animal relationship.
Professor Day said: "It is well recognised that most of the major new diseases of mankind will have an animal origin and that dogs and cats are a potential source of such emerging diseases.
"The number of small companion animals is particularly significant. For example there are an estimated eight to ten million dogs living in up to 31 per cent of UK homes and in the USA, 72 million dogs in 37 per cent of homes. The benefits of pet ownership on human health, well-being and development are unquestionable but, as they have moved from the barn, to the house, to the bedroom, the potential for disease spread to humans increases. Control of diseases among dogs and cats is a good way to prevent spread to humans.
"In human, livestock and wildlife heath there are already programmes of active surveillance for infectious disease underway to monitor the global distribution and movement of key infectious agents. For example, the WHO monitors human influenza virus infection through a network of 111 centres in 83 countries. In contrast, there is no such monitoring for the infections that may be transmitted between small companion animals and man. Meanwhile, canine rabies virus infection, one of the diseases listed in the paper, is estimated to kill a minimum of 55,000 people in Africa and Asia each year.
"The development of such a scheme would require the significant political will, scientific application and financial support that could be achieved through a public-private partnership. The aim of our position paper in Emerging Infectious Diseases is to initiate stakeholder discussions with that end goal in mind."
Presenters at the webinar will include: Professor Melissa McDermid MD, MPH, division head, Occupational & Environmental Medicine, University of Maryland, Prof. Clare Knottenbelt BVSC MSC DSAM MRCVS, owner and founder of specialist referral service, Hawk and Dove, and previously clinical director of the Small Animal Hospital at the University of Glasgow Veterinary School, Sam Fontaine MSc, lecturer and director of the MSc Advanced Practice in Veterinary Nursing and module leader within the BVMS programme at The Glasgow School of Veterinary Medicine. There will also be a video from the oncology centre at The Queen’s Veterinary School, Cambridge University.
The webinar will also look at the use of Closed System Transfer Devices, such as Tevadaptor, to improve safety and break down barriers to treatment across all practices.
Clare Knottenbelt (pictured right) said: “Pets with cancer need to be able to access chemotherapy treatments locally. The advent of new closed administration systems mean that practices can now safely administer chemotherapeutics in house without the need for large investment, but still protecting the health of their staff."
Delegates will be able to to submit questions to the speakers and will receive a certificate for one hour of CPD. The session will be recorded so it can be watched again.
For the full programme or to register, visit: https://aesculap-academia.eventbritestudio.com/160802290981
The European Society of Feline Medicine (ESFM) is expanding the scope and reach of its Journal of Feline Medicine and Surgery (JFMS) in January 2009 by moving to a monthly schedule and introducing six colourful new clinical issues which will alternate with the now well-established classic issues.
JFMS, the official journal of both ESFM and of the American Association of Feline Practitioners (AAFP), has an excellent citation index and is ever-growing with record numbers of high quality papers being received. The clinical issues of JFMS will be highly visual and contain commissioned clinical review articles enhanced by case work-ups, self-assessment questions and multimedia online elements to provide practitioners with the latest author guided evidence-based information as a tool for day-to-day feline treatment.
‘As a practitioner-orientated organisation we wanted to do more for the vet in practice. So, for ESFM's 10th anniversary we are again breaking the mould by introducing six new issues a year containing well illustrated clinical reviews, aimed specifically at practice, from the best authors around the world,' said Claire Bessant Chief Executive of the ESFM and its founding organisation the Feline Advisory Bureau (FAB).
‘The aim of JFMS ‘clinical' is to turn vision into reality by delivering opinionated reviews, and some ‘outside the box' thinking, from respected clinicians to the front line of veterinary practice,' says JFMS editor Dr Andy Sparkes.
From January, members of ESFM will receive a monthly journal - six classic (the current JFMS) and six JFMS clinical issues - classic and clinical - pure and applied - the best of feline veterinary science.
If you would like a mini-sample of the new journal then contact the FAB/ESFM office Margaret@fabcats.org or go to www.fabcats.org/esfm where you can download a pdf or view it on screen.
Individual membership of ESFM is £110 pa (Euros 145) for UK and overseas. Practice membership is £170 for the UK, £190 overseas (soruE 240). ESFM members are entitled to reduced rates to ESFM congress and gain online access to JFMS papers. Full details are available at www.fabcats.org/esfm.
Petplan has issued a last call for entries to the 2009 Petplan Veterinary Awards, and announced that comedian Jason Manford, best known as team captain on Channel 4's 8 out of 10 Cats, will be the compere.
The Veterinary Awards aim to honour the special stars within the veterinary profession and nominations remain open under four different categories:
Petplan says it has already received hundreds of nominations from clients and industry professionals alike. To make sure your colleagues are considered for the accolade log onto www.petplan.co.uk/vetawards to nominate. Entries must be in by 6th February 2009.
The Petplan Veterinary Awards are to be held on Thursday 2nd April on the first evening of BSAVA.
Vétoquinol has announced that Zylkène, a complementary feed used to help pets cope with unpredictable situations, is now available in a 20 capsule pack.
The new packs have been designed to have more 'stand out appeal' on the shelves. Veterinary practices will now be able to display the new packs in waiting rooms and reception areas in a custom-made display unit to generate interest from pet owners and increase revenue for the practice.
Krystyna Joyce, Product Manager at Vétoquinol, said: "This has a huge benefit for the vet practice. As well as increased revenue, pet owners are much more likely to initiate a discussion about behaviour if they can see that there is a product to help their pet adjust to unusual circumstances or environmental changes."
Krystyna added: "With a number of behaviour products on the market, it can be confusing for pet owners to know which ones can be used when. We want to make it easier for pet owners: now when they come to their vets, they can see Zylkène, know what it's for, understand which strength will be right for their pet and pick it up."
As well as increasing product awareness, the packs will work alongside Vétoquinol's ongoing series of pet owner guides which offer advice on how best to help an animal deal with an unusual situation or life change.
Zylkène retail packs are available now from any veterinary wholesaler.
It will compare current prescription levels with two-year retrospective data to gain an understanding of prescribing behaviour.
It will also look at the proportion of prescriptions that are Highest Priority Critically Important Antimicrobials (HPCIAs).
Individual practice data will then be given to a dedicated AMS representative at each surgery who will be responsible for sharing it with their team - to gain an understanding of their prescribing for these conditions and to review actions which can be taken at practice level.
CPD on antimicrobial stewardship will be given to all practices to encourage responsible antimicrobial usage.
The research project will then capture ongoing data - from August 2024 until July 2025 - to show changes in antimicrobial prescribing.
The research is expected to provide an opportunity to build upon ongoing veterinary antimicrobial stewardship strategies.
This could include: using diagnostics to ensure accurate diagnoses and appropriate treatment plans, informing a change in prescribing behaviour, selecting antimicrobials responsibly, educating pet owners on antimicrobial resistance and using evidence-based guidance.
The clinical research project is being run by Kezia Wareham, Doctor of Philosophy student at Bristol Veterinary School (supervised by Dr Fernando Sanchez-Vizcaino, Dr Emi Barker, Dr Nicola Rooney and Dr Irene Bueno Padilla) and Deb Komianos, Regional Clinical Lead at CVS.
Deb said: “Antimicrobial resistance is one of the top ten global health threats and the figures projected by the WHO for attributable deaths are truly startling.
"To address the development of drug-resistant pathogens requires a One Health approach.
"It is not enough to pay lip service to AMS, we need to be leading the change."
CPD Solutions have announced 3 new dentistry and oral surgery course dates, with expert tutor Alex Smithson of the Dental, Oral and Maxillofacial Referrals in Lancashire.
All courses will include extensive wet lab sessions, which will cover conditions commonly seen in practice and answer all those questions you always wanted to ask but never had the time to look up!
For details visit http://www.cpd-solutions.com/ or call 0151 328 0444 and ask for Holly.
Intervet has announced that its bluetongue vaccine, Bovilis® BTV8 has been granted a licence by the Veterinary Medicines Directorate (VMD). The licence, which is the first for a bluetongue vaccine in the UK, sets out dose rates and treatment regimes for the product use.
The recommended dose rates for animal over one month of age are as follows:
Sheep – 1 x 1ml, injected subcutaneously.
Cattle - 2 x 1ml, approximately three weeks apart, injected subcutaneously.
In successive years, re-vaccination should be given two weeks prior to the risk period.
Treated animals should have protective immunity three weeks after the initial course. Bovilis BTV8 should only be administered to healthy animals. Treated stock may have a slight swelling at the site of injection.
The vaccine must be stored at between 2ºC – 8ºC and, once opened, should be used within eight hours. The vaccine is available in 20ml and 50ml bottles. The licence recommends the use of multi injection vaccination systems.
Intervet will be supplying a discounted 1ml vaccination gun into the market.
The Society of Practising Veterinary Surgeons (SPVS) has inaugurated its new President Iain Richards BVSc CertVA Cert SHP MRCVS, who has outlined the key issues he would like to address during his presidency:
"The reform of the Veterinary Surgeons Act will be a big part of the SPVS year. Any changes of the VSA are likely to hit practitioners hardest of all. It was to ensure public confidence that the RCVS was formed, and it is with the public that we have our daily interactions. It is satisfying to note, despite what some of the EFRACOM committee felt, that the proportion of actual complaints in comparison to public interactions is very small indeed. This point must not be lost on the RCVS or government. The profession is already held in high esteem by the public and any new act has to reinforce that.
Alongside the VSA are the closely related aspects of 24hr cover and the Working Time Regulations. Indeed, it is no coincidence that our high public esteem is in part due to the willingness of the practicing arm of the profession to make itself available at all times. The WTR has a long way to go, but has the potential to make this aspect of our work untenable.
Farm practice continues to have its own challenges. Despite opinion suggesting that farms do well in a recession, the challenges are still out there. It is a rapidly changing field with issues of medicines supply still causing problems. TB will spread and more practices will have to look hard at the return LVI work provides. By adopting SPVS advice on fee construction and cost centre analysis, practices can accurately assess the true impact of this and any other revenue stream.
Small animal and many equine practices will potentially feel the recession the most, as both operate in a luxury market. The 2009 Congress theme, and that of the SPVS stream at the BVA Congress in Cardiff, is "Surviving the Recession".
The Society will be at the forefront in providing solid advice to practices to enable them to thrive in such circumstances. Recessions have come and gone and we have a wealth of experience from previous SPVS members to draw upon. One thing is clear, providing a quality service is vital. To the client, this has to be a value for money service as well. Marrying these two is key to business success and SPVS council will be working towards these objectives. It is likely that those practices that adapt and survive a recession will be in a strong position in the future.
Quality and value apply to practices, regardless of their species grouping. At home in Kendal, my practice is pushing standards forwards in equine, farm and small animal work. Because of this I am lucky to be able to indulge in being a mixed practitioner who has a keen interest in all aspects of veterinary work. This places me in a good position to represent the Society of Practising Veterinary Surgeons at all levels and to all bodies. SPVS is a great society; it is a pleasure to be picked for the team.
My vision goes beyond the year, however, and would encapsulate a desire that SPVS works with the other divisions of BVA to ensure that the veterinary profession provides the foremost view of all aspects of animal welfare and disease."
Janssen Animal Health is advising vets to be on the look out for coccidiosis as the spring lambing season approaches: cases usually rise in March and peak in April and May.
According to the company, some reports also suggest that the incidence of coccidiosis in calves may apparently increase during the grazing months. However, vets are reporting that interpretation of laboratory tests used to confirm diagnosis, such as oocyst count, can be problematic due to the ubiquitous nature of the Eimeria parasite in the UK.
Young animals may be infected by oocysts shed by asymptomatic carriers or infected older cohort animals. Low levels of challenge can help young animals develop immunity but exposure to high oocyst numbers, particularly in combination with stress can lead to clinical and subclinical forms of the disease. Diagnosis can be problematic, particularly in subclinical cases of disease where failure to gain weight is the main presenting sign and in clinical cases the differential diagnoses include all causes of scour in young animals.
Janssen Animal Health has suggested a few indicators that may be useful in identifying cases of coccidiosis. The Vecoxan Coccidiosis Survey in 2008 and 2009 asked farmers about their experiences of coccidiosis and identified that bad weather was a major trigger particularly in lambs; while castration and weaning were also factors in calves. As the parasite life cycle is 21 days, vets should be alert to disease 2-3 weeks after a stressor event.
The company has also suggested a few guidelines to aid interpretation of laboratory results:
Janssen says Vecoxan (diclazuril) does not interfere with the development of immunity and kills all stages of the parasite in the host.
The National Office of Animal Health has released two films to help industry and consumers understand issues surrounding the use of animal medicines in the food chain.
A film made for the food chain industry titled "Animal Medicines in Food Production - The Food Industry Perspective" has been produced to help industry understand the levels of awareness and concerns that consumers have.
A second film, "Animal Medicines in Food Production - Challenging the Myths" is aimed at consumers and looks at some of the myths surrounding the use of animal medicines in livestock production.
Phil Sketchley, Chief Executive of NOAH, said that while the public was generally supportive of the use of animal medicines in farm production, there was a knowledge gap among consumers about the way that medicines were used: "It was interesting to discover how much people knew about medicines in food production. There were some very positive attitudes among consumers, particularly towards the way British farmers care for their animals. But there were still some areas of concern, for example with the belief among a large number of people that growth hormones were still being used on UK farms, despite the fact they have been banned since 1988.
"The industry film should help people involved in food production understand what consumers are thinking when it comes to animal medicines. Animal health and welfare and ensuring sick animals are treated is a big issue, and food producers and retailers need to be able to communicate clearly with consumers on the subject of animal medicines.
"It is important there is transparency on all issues of animal health and welfare."
The grants are available for small-scale clinical research projects in areas of the affiliate speciality, focusing on diseases affecting companion animals.
The projects will be selected in the hope that the study results will have a rapid and positive impact on the way diseases are diagnosed, managed and treated in general practice, as well as at a specialist level.
BSAVA says applications are particularly welcome from practitioners, as well as academics or joint applications between practice and academia.
Chris Scudder, from the Small Animal Medicine Society said: “We are delighted to be able to collaborate with BSAVA PetSavers in supporting innovative research in small animal internal medicine.
"We have a shared goal of advancing the health and well-being of small animals.
"Their invaluable and generous support enables us to fund research that makes a meaningful difference for cats, dogs, and their owners.”
Applications are also open for the BSAVA PetSavers Clinical Research Project grant, where funding of up to £20,000 is available.
https://bsava.com/petsavers/apply-for-funding/clinical-research-projects/.